Genetic test for cancer is less accurate for Black and Asian people
By Grace Wade,
New Scientist
| 09. 29. 2022
Genetic tests that predict the efficacy of certain cancer treatments aren’t as effective for people of African or Asian ancestry.
These tests measure the number of genetic mutations in solid tumours, or what’s known as tumour mutational burden (TMB). If someone has a tumour with 10 or more genetic mutations, they have a high TMB. Drugs called immune checkpoint inhibitors, which work by turning the immune system against tumours, have been shown to be quite effective against cancers in people with high TMB, but less so in people with fewer mutations.
The most accurate way to measure TMB is by doing genetic analyses of both tumour and normal tissue samples. This is called tumour-normal sequencing, and it ensures that mutations people inherent from their parents aren’t counted as tumour mutations. “If you don’t have matched normal tissue from an individual, you can actually overestimate the tumour mutational burden,” says Amin Nassar at Yale University in Connecticut.
Most treatment centres currently use tumour-only genetic sequencing, which estimates TMB by comparing results with genetic databases instead of a person’s own tissue...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
